Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melats P in Polycystic Ovarian Syndrome
NCT07399535Phase 1Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of Melats P in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoint: Regulation of Menstrual Cycle at 4 months. Started Feb 2025; status: completed.
02
Drugs
Melats P
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07399535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07399535.